Roledumab
From Wikipedia, the free encyclopedia
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | RHD |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| | |
Roledumab is a monoclonal antibody. It binds to RHD, the Rhesus factor antigen.[1][2]
It is currently at Phase III trials for Rh disease.